About this episode
In this interview, we review some of the remarkable benefits of low-dose naltrexone (LDN), including the surprising benefits of microdosed LDN. The two experts featured in this interview are Linda Elsegood, a Briton who founded the LDN Research Trust in 2004, and Dr. Sarah Zielsdorf, who has a medical practice in the Chicago area in the U.S.